7PZ7

Structure of an LPMO at 1.13x10^6 Gy


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.170 
  • R-Value Work: 0.134 
  • R-Value Observed: 0.136 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Changes in active-site geometry on X-ray photoreduction of a lytic polysaccharide monooxygenase active-site copper and saccharide binding.

Tandrup, T.Muderspach, S.J.Banerjee, S.Santoni, G.Ipsen, J.O.Hernandez-Rollan, C.Norholm, M.H.H.Johansen, K.S.Meilleur, F.Lo Leggio, L.

(2022) IUCrJ 9: 666-681

  • DOI: https://doi.org/10.1107/S2052252522007175
  • Primary Citation of Related Structures:  
    7PQR, 7PXI, 7PXJ, 7PXK, 7PXL, 7PXM, 7PXN, 7PXR, 7PXS, 7PXT, 7PXU, 7PXV, 7PXW, 7PYD, 7PYE, 7PYF, 7PYG, 7PYH, 7PYI, 7PYL, 7PYM, 7PYN, 7PYO, 7PYP, 7PYQ, 7PYU, 7PYW, 7PYX, 7PYY, 7PYZ, 7PZ0, 7PZ3, 7PZ4, 7PZ5, 7PZ6, 7PZ7, 7PZ8

  • PubMed Abstract: 

    The recently discovered lytic polysaccharide monooxygenases (LPMOs) are Cu-containing enzymes capable of degrading polysaccharide substrates oxidatively. The generally accepted first step in the LPMO reaction is the reduction of the active-site metal ion from Cu 2+ to Cu + . Here we have used a systematic diffraction data collection method to monitor structural changes in two AA9 LPMOs, one from Lentinus similis ( Ls AA9_A) and one from Thermoascus auranti-acus ( Ta AA9_A), as the active-site Cu is photoreduced in the X-ray beam. For Ls AA9_A, the protein produced in two different recombinant systems was crystallized to probe the effect of post-translational modifications and different crystallization conditions on the active site and metal photoreduction. We can recommend that crystallographic studies of AA9 LPMOs wishing to address the Cu 2+ form use a total X-ray dose below 3 × 10 4  Gy, while the Cu + form can be attained using 1 × 10 6  Gy. In all cases, we observe the transition from a hexa-coordinated Cu site with two solvent-facing ligands to a T-shaped geometry with no exogenous ligands, and a clear increase of the θ 2 parameter and a decrease of the θ 3 parameter by averages of 9.2° and 8.4°, respectively, but also a slight increase in θ T . Thus, the θ 2 and θ 3 parameters are helpful diagnostics for the oxidation state of the metal in a His-brace protein. On binding of cello-oligosaccharides to Ls AA9_A, regardless of the production source, the θ T parameter increases, making the Cu site less planar, while the active-site Tyr-Cu distance decreases reproducibly for the Cu 2+ form. Thus, the θ T increase found on copper reduction may bring Ls AA9_A closer to an oligosaccharide-bound state and contribute to the observed higher affinity of reduced Ls AA9_A for cellulosic substrates.


  • Organizational Affiliation

    Department of Chemistry, University of Copenhagen, Universitetsparken 5, 2100-DK, Copenhagen, Denmark.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Gh61 isozyme a228Thermoascus aurantiacusMutation(s): 0 
EC: 3.2.1.4
UniProt
Find proteins for G3XAP7 (Thermoascus aurantiacus)
Explore G3XAP7 
Go to UniProtKB:  G3XAP7
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupG3XAP7
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
HIC
Query on HIC
A
L-PEPTIDE LINKINGC7 H11 N3 O2HIS
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.170 
  • R-Value Work: 0.134 
  • R-Value Observed: 0.136 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 34.43α = 90
b = 87.38β = 104.9
c = 37.45γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
XSCALEdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Novo Nordisk FoundationDenmarkNNF17SA0027704
Danish Council for Independent ResearchDenmark8021-00273B

Revision History  (Full details and data files)

  • Version 1.0: 2022-08-24
    Type: Initial release
  • Version 1.1: 2022-09-21
    Changes: Database references
  • Version 1.2: 2024-01-31
    Changes: Data collection, Refinement description